Varicocele Treatment and Infertility: A Complete Guide to When Surgery Can Help

A varicocele is an excessive dilatation of the pampiniform plexus, the network of veins that drains the testicle within the spermatic cord. According to a 2025 review published on PubMed Central, varicocele affects approximately 10–20% of the general male population and 35–40% of men presenting with primary infertility, establishing it as the most common surgically correctable cause of male infertility.

Varicoceles occur predominantly on the left side because the left testicular vein drains at a right angle into the left renal vein, creating higher venous pressure. Bilateral varicoceles also occur, and isolated right-sided varicoceles are rare enough to warrant imaging to exclude a secondary cause such as a retroperitoneal mass.

The condition is graded clinically using the Dubin and Amelar system: Grade I is palpable only during the Valsalva manoeuvre (bearing down), Grade II is palpable at rest without Valsalva, and Grade III is visible to the naked eye without palpation. This grading matters clinically because treatment decisions depend on whether the varicocele is clinically palpable.

Varicocele causes infertility through at least four overlapping mechanisms, all of which disrupt the delicate intratesticular environment required for healthy sperm production (spermatogenesis). As detailed in the 2025 PMC review, these are: elevated scrotal temperature from pooled venous blood, hypoxia caused by venous stasis, reflux of toxic metabolites from the renal and adrenal veins, and excessive reactive oxygen species (ROS) that damage sperm DNA.

Scrotal temperature is normally 2–3 °C below core body temperature, a prerequisite for normal spermatogenesis. Dilated veins act like a radiator running in reverse, raising testicular temperature and slowing or halting sperm production. Simultaneously, venous stasis reduces oxygen delivery to the germinal epithelium, and retrograde flow carries adrenal hormones and renal metabolites directly into the testicular circulation.

The resulting oxidative stress is particularly damaging because it causes sperm DNA fragmentation, breaks in the genetic material carried by sperm. High DNA fragmentation reduces fertilisation rates, impairs embryo development, and raises the risk of miscarriage, even when standard semen parameters appear only mildly abnormal. This is why a normal-looking semen analysis does not always rule out a clinically significant varicocele.

Beyond sperm production, varicocele treatment and infertility management must account for the hormonal dimension. The same 2025 PMC review notes that varicocele may negatively affect Leydig cell function, the cells responsible for testosterone synthesis, and may lower testosterone and disrupt the hypothalamic-pituitary-gonadal (HPG) axis; the testosterone data it cites come from animal studies.

Clinically, this can present as reduced libido, fatigue, or signs of hypogonadism alongside infertility. When a consultant suspects hormonal involvement, a full hormone profile including serum testosterone, luteinising hormone (LH), and follicle-stimulating hormone (FSH) is requested alongside the standard semen analysis. Elevated FSH in particular may indicate significant testicular damage and influences the choice between surgical repair and proceeding directly to assisted reproduction.

Importantly, a meta-analysis summarised in a 2025 Journal of Clinical Medicine review reported a significant rise in serum testosterone after varicocele repair (mean difference about 82 ng/dL). Repair for hypogonadism is an expanding indication, but high-level evidence is still limited.

Diagnosis of varicocele in the context of infertility begins with a careful physical examination performed while the patient is standing, both at rest and during the Valsalva manoeuvre. According to the 2025 PMC review, clinical examination remains the primary diagnostic tool; scrotal Doppler ultrasound is reserved for cases where the clinical finding is equivocal or where recurrence after treatment is suspected.

On ultrasound, a varicocele is confirmed when venous diameter exceeds 3 mm and retrograde flow (reflux) lasts more than 2 seconds during Valsalva. Ultrasound also allows measurement of testicular volume, which is particularly important in adolescents and in men where testicular atrophy is suspected. A discrepancy of more than 20% between the two testes is clinically significant.

Semen analysis based on the WHO 2021 reference values is an essential part of the workup. The team at Jananam evaluates sperm concentration, total motility, progressive motility, and morphology, and will often add a sperm DNA fragmentation test where standard parameters are only mildly abnormal. You can learn more about the full ovarian reserve and male fertility testing pathway that informs treatment planning at the clinic.

• Diagnostic Step: Standing physical exam + Valsalva · What It Assesses: Palpability and grade (I–III) · When It Is Used: All men with suspected varicocele
• Diagnostic Step: Scrotal Doppler ultrasound · What It Assesses: Vein diameter >3 mm, reflux >2 s, testicular volume · When It Is Used: Equivocal exam, suspected recurrence
• Diagnostic Step: Semen analysis (WHO 2021) · What It Assesses: Concentration, motility, morphology · When It Is Used: All infertile men with varicocele
• Diagnostic Step: Sperm DNA fragmentation test · What It Assesses: Integrity of sperm genetic material · When It Is Used: Mild semen abnormality or recurrent miscarriage
• Diagnostic Step: Hormone profile (T, LH, FSH) · What It Assesses: Leydig cell function, HPG axis · When It Is Used: Signs of hypogonadism or elevated FSH

Varicocele treatment and infertility intervention is indicated when three conditions are met simultaneously: the varicocele is clinically palpable (Grade I–III on examination), the semen analysis shows one or more abnormal parameters, and the female partner's fertility has been evaluated and is either normal or treatable. The 2025 PMC review is explicit that treatment is not recommended for subclinical varicoceles detected only on imaging, because the evidence of benefit in that group is absent.

Persistent dull scrotal ache or heaviness that does not resolve with conservative measures (supportive underwear, anti-inflammatories) is an independent indication for repair, even in men not currently trying to conceive. Post-surgical pain relief is reported in approximately 80% of men, making varicocele repair a well-evidenced option for this symptom.

In adolescents, the threshold for intervention is a testicular volume discrepancy of more than 20% between the two sides, an abnormal semen analysis where one is available, or persistent pain. Because some adolescents show spontaneous catch-up testicular growth, a watchful-waiting period of 6–12 months is generally advised before committing to surgery, unless the discrepancy is severe or progressive.

• Palpable varicocele (Grade I, II, or III) confirmed on physical examination
• At least one abnormal semen parameter on WHO 2021 criteria
• Female partner evaluation completed, fertility normal or addressable
• Persistent scrotal pain unresponsive to conservative management
• Adolescent with >20% testicular volume discrepancy or abnormal semen
• Subclinical (imaging-only) varicocele without semen abnormality, treatment not indicated

Three broad approaches exist for varicocele treatment and infertility management: microsurgical varicocelectomy (subinguinal or inguinal), laparoscopic or open retroperitoneal ligation, and radiological embolization or sclerotherapy. The 2025 PMC review identifies microsurgical varicocelectomy as the recommended standard because it has shown the highest success and lowest recurrence rate.

Microsurgical varicocelectomy uses optical magnification (operating microscope or loupe) to identify and ligate all dilated veins while preserving the testicular artery, vas deferens, and lymphatic channels. Preserving the lymphatic channels is a core principle of the operation and helps lower the risk of post-operative hydrocele (fluid collection around the testicle). Pregnancy rates of up to 42% have been reported with this technique, and the complication rate is low in experienced hands.

Laparoscopic varicocelectomy allows a bilateral approach through small abdominal incisions and is useful when both sides require treatment simultaneously. However, it carries higher rates of hydrocele formation and recurrence compared with microsurgical techniques, and requires general anaesthesia. Radiological embolization, threading a catheter through the groin or neck vein to block the testicular vein with coils or foam, is the least invasive option and avoids a surgical incision, but the spermatic vein cannot be reached in about 8–30% of patients, there is a small risk of embolic migration, recurrence is higher, and radiation exposure is a consideration.

• Technique: Microsurgical varicocelectomy · Approach: Subinguinal or inguinal incision + microscope · Pregnancy Rate: Up to 42% · Recurrence Risk: Lowest · Key Advantage: Preserves artery and lymphatics; gold standard
• Technique: Laparoscopic varicocelectomy · Approach: 3 small abdominal ports, general anaesthesia · Pregnancy Rate: Comparable · Recurrence Risk: Moderate · Key Advantage: Bilateral treatment in one procedure
• Technique: Open retroperitoneal ligation · Approach: Flank incision, higher ligation · Pregnancy Rate: Comparable · Recurrence Risk: Moderate · Key Advantage: Simple technique; no microscope needed
• Technique: Radiological embolization / sclerotherapy · Approach: Percutaneous catheter, local anaesthesia · Pregnancy Rate: Comparable when successful · Recurrence Risk: Higher than microsurgery · Key Advantage: No surgical incision; day procedure

The evidence base for varicocele treatment and infertility outcomes is substantial. The 2025 PMC review cites a Cochrane review in which treating varicocele in subfertile men improved spontaneous pregnancy rates (odds ratio 1.47), though it notes the evidence was low-level. It also reports that repair showed no demonstrable benefit for subclinical varicoceles, so the benefit applies to men with clinically palpable varicoceles and abnormal semen parameters.

A meta-analysis summarised in the 2025 PMC review (Wang et al., Asian Journal of Andrology, 2015) reported pregnancy rates of 42% after subinguinal microsurgical varicocelectomy, 35% after inguinal microsurgical varicocelectomy and 37% after laparoscopic surgery, compared with 17% without treatment. Semen parameter improvements of 60–80% have been reported after repair.

Recurrence after surgery is most often caused by incomplete ligation of spermatic or cremasteric veins and is more common with less experienced surgeons or non-microsurgical techniques. When clinical improvement is absent three to six months after repair, Doppler ultrasound is the recommended next step to identify persistent or recurrent venous reflux.

Varicocele treatment and infertility management before assisted reproductive technology (ART) is an important strategic question for couples. A 2020 review published on PMC summarised a meta-analysis (Kirby et al., Fertility and Sterility, 2016) in which varicocele repair before ART was associated with a higher live birth rate in men with low or absent sperm counts. The review supports repair before ART for couples where the man has a clinical varicocele and abnormal semen parameters and the female partner has good ovarian reserve.

The rationale is straightforward: improving sperm quality before IVF or ICSI reduces the number of cycles needed, lowers the overall cost of treatment, and may allow some couples to achieve a spontaneous pregnancy, avoiding ART altogether. A 2023 conference abstract in the Journal of Urology used a Markov model and concluded that subfertile couples with a varicocele may save time and money by evaluating the male partner first, before treatment.

The decision to repair before or proceed directly to ART depends on the female partner's age and ovarian reserve, the severity of the male factor, and how much time the couple has. Where the female partner is over 38 or has diminished ovarian reserve, the team at Jananam will typically weigh the 3–6 month recovery window against the urgency of proceeding with ART, and may recommend concurrent or sequential strategies.

Non-obstructive azoospermia (NOA), the complete absence of sperm in the ejaculate due to impaired production rather than a blockage, is one of the most challenging presentations in male infertility. Varicocele treatment and infertility outcomes in this group are more nuanced but genuinely encouraging. According to a 2025 study in the World Journal of Men's Health, varicocele repair in men with NOA leads to sperm reappearing in the ejaculate in 20–55% of cases, particularly in men whose testicular biopsy shows hypospermatogenesis or early maturation arrest rather than complete Sertoli-cell-only syndrome.

Even when sperm do not reappear spontaneously in the ejaculate, varicocele repair improves sperm retrieval rates during microsurgical testicular sperm extraction (micro-TESE), the procedure used to harvest sperm directly from testicular tissue for use in ICSI. This means that for men with NOA and a palpable varicocele, repair before micro-TESE is a reasonable strategy to maximise the chance of finding usable sperm.

Men with azoospermia and a varicocele should have a thorough hormonal and genetic evaluation, including karyotype and Y-chromosome microdeletion testing, before any treatment decision, because certain genetic causes of NOA will not respond to varicocele repair. Your consultant at Jananam will interpret these results in the context of the full clinical picture before recommending a pathway.

Male factor infertility, including varicocele, accounts for a significant proportion of couples seeking fertility care across India, yet it remains underdiagnosed in many settings where the focus defaults to female investigations. Varicocele treatment and infertility management at a dedicated single-speciality centre ensures that the male partner receives the same rigorous evaluation as the female partner from the outset, rather than as an afterthought.

Jananam Fertility Centre in Neelankarai, Chennai, is a single-speciality fertility clinic treating infertility only. The team's consultants bring over two decades of combined experience in reproductive medicine, and the clinic's Certified Cleanroom Laboratory is particularly relevant for couples where varicocele has caused sperm DNA damage, because laboratory conditions directly affect how fragile sperm perform during fertilisation and early embryo development.

For couples where varicocele repair is indicated before ART, Jananam coordinates the surgical referral and the subsequent fertility workup so that the transition from repair to IVF or IUI is seamless. Where the female partner has PCOS, endometriosis, or recurrent miscarriage, both partners' conditions are managed in parallel rather than sequentially, saving valuable time.

Microsurgical varicocelectomy remains the gold standard for varicocele treatment and infertility management, but the field is evolving rapidly. A 2025 review in the Journal of Clinical Medicine highlights emerging molecular biomarkers that may predict which men will respond best to repair, artificial intelligence models being developed to optimise patient selection, and imaging advances such as shear wave elastography that may improve diagnostic accuracy.

Expanded indications are also under investigation, including varicocele repair for hypogonadism without infertility, and refined protocols for men with NOA. High-quality randomised controlled trials (RCTs) with live birth as the primary endpoint are still needed to resolve ongoing debates about the benefit of repair in borderline cases, such as men with mild semen abnormalities or subclinical varicoceles detected only on ultrasound.

For patients today, the practical implication is that treatment decisions should be made at a centre that stays current with evolving evidence and can offer the full spectrum of options, from watchful waiting and lifestyle optimisation through to microsurgical repair and advanced ART including pre-implantation genetic testing, rather than a one-size-fits-all approach.